Actinium Announces Iomab-B IND Has Been Cleared By FDA; Pivotal, Phase 3 Trial to Proceed Dec 17, 2015
Clinical Trial Results for Actimab-A Presented at the 57th American Society of Hematology Annual Meeting Dec 8, 2015
Actinium Announces Strong Presence at 57th American Society of Hematology Annual Meeting December 4-8, 2015 Dec 1, 2015
Actinium Files Orphan Drug Application for Use of Iomab-B in Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients Nov 23, 2015
Actinium Pharmaceuticals Further Strengthens Product Development Efforts With Senior Level Hires Nov 4, 2015
Actinium Announces Data From Actimab-A Trial has Been Accepted for Poster Presentation at American Society of Hematology Annual Meeting Oct 26, 2015
